Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: AJNR Am J Neuroradiol. 2016 Jul 21;37(12):2273–2279. doi: 10.3174/ajnr.A4886

Table 2.

Metabolite Controls Patients p-value
NAA a8.7±1.2 (n=11) a8.8±1.6 (n=16) 0.876
Cr a7.4±1.2 (n=10) a8.7±2.2 (n=19) 0.035
Cho a2.1±0.3 (n=10) a2.3±0.7 (n=18) 0.189
mIns a5.2±0.9 (n=10) a6.1±1.5 (n=12) 0.161
Volume (cm3) 8.4±0.5 (n=11) 7.5±0.9 (n=19) 0.003

Means ± Standard deviation, number of subjects from whom the data was derived n (in parentheses), and p-values (from unequal variance T tests) of the absolute NAA, Cr, Cho and mIns hippocampal GM concentrations a(millimolar), as well as the volumes of the bilateral hippocampi in controls and patients (in cm3). Significant differences are in boldface; note elevation of Cr and reduction in volume in patients compared to controls.